Grant: Alliance Grants
University of Calgary
$250,000.00
Development of a sensitive and dynamically responding electrochemical pathogen sensor platform technology
FY 2024-25
Summary
The world is facing massive challenges in detecting and responding to naturally-occurring highly virulent pathogens that the public may encounter and to the purposeful weaponization of biological agents. One critical gap is that present-day pathogen sensors are designed to detect only a single known pathogen (e.g., E coli in meat), which is inadequate against exposure to new genetically engineered pathogens, especially in military settings where unknown pathogens may be purposefully deployed. In recent years, our team has been developing a novel platform technology aimed at the rapid detection of pathogens, e.g., bacteria, fungi and viruses. This technology relies on a sensitive and selective electrochemical sensor design involving attachment of Toll-like receptors (TLRs) to various self-assembled monolayers (SAMs), tethered to gold electrodes. TLRs are bio-recognition elements from the innate immune system that selectively recognize classes of pathogen-associated molecular patterns (PAMPs). While our current sensors respond rapidly and selectively to these PAMPs, further down-selection of the electrodes (to lower cost by using carbon vs. gold) and the binding groups (common thiols vs more stable carbenes) that attach the SAMs to the electrode is needed. Further, the sensor dynamic response to variable PAMP concentrations must be determined to assess performance in fluctuating PAMP concentrations and the potential for sensor reuse. The project will also involve the construction of a commercializable platform, e.g., sensing strips for one-time flow assay purposes or reusable multiplexed chips for analyzing both environmental and clinical samples. The partner organizations supporting this project are Defence Research and Development Canada, Suffield Research Centre (DRDC SRC) and CardiAI Inc., a successful Calgary-based Canadian SME that is developing diagnostic devices for the electrochemical screening of clinical samples for heart failure biomarkers and indicators of infections. This project, which will train up to 20 students, is therefore of utmost strategic importance to Canada.
Program
Alliance Grants
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
590441-2023
Name nom
Birss, Viola VI
Department département
Chemistry
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
250000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Development of a sensitive and dynamically responding electrochemical pathogen sensor platform technology
Keywords
biosecurity; carbenes; clinical samples; electrochemistry; environmental samples; pathogen-associated molecular patter; pathogen sensors; self-assembled monolayers; thiols; toll-like-receptors
Application summary
The world is facing massive challenges in detecting and responding to naturally-occurring highly virulent pathogens that the public may encounter and to the purposeful weaponization of biological agents. One critical gap is that present-day pathogen sensors are designed to detect only a single known pathogen (e.g., E coli in meat), which is inadequate against exposure to new genetically engineered pathogens, especially in military settings where unknown pathogens may be purposefully deployed. In recent years, our team has been developing a novel platform technology aimed at the rapid detection of pathogens, e.g., bacteria, fungi and viruses. This technology relies on a sensitive and selective electrochemical sensor design involving attachment of Toll-like receptors (TLRs) to various self-assembled monolayers (SAMs), tethered to gold electrodes. TLRs are bio-recognition elements from the innate immune system that selectively recognize classes of pathogen-associated molecular patterns (PAMPs). While our current sensors respond rapidly and selectively to these PAMPs, further down-selection of the electrodes (to lower cost by using carbon vs. gold) and the binding groups (common thiols vs more stable carbenes) that attach the SAMs to the electrode is needed. Further, the sensor dynamic response to variable PAMP concentrations must be determined to assess performance in fluctuating PAMP concentrations and the potential for sensor reuse. The project will also involve the construction of a commercializable platform, e.g., sensing strips for one-time flow assay purposes or reusable multiplexed chips for analyzing both environmental and clinical samples. The partner organizations supporting this project are Defence Research and Development Canada, Suffield Research Centre (DRDC SRC) and CardiAI Inc., a successful Calgary-based Canadian SME that is developing diagnostic devices for the electrochemical screening of clinical samples for heart failure biomarkers and indicators of infections. This project, which will train up to 20 students, is therefore of utmost strategic importance to Canada.